Early research (Phase 1)Looking for participantsNCT06136884
What this trial is testing
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
Who this might be right for
Solid Tumor MalignanciesBrain Metastases From Solid Tumors
A2A Pharmaceuticals Inc. 86